TraceLink, helping the pharma industry trace and track drugs, lands $51.5M from Goldman Sachs

 TraceLink, the SaaS platform for tracking and tracing pharmaceuticals, has today announced the close of a $51.5 million Series C financing led by Goldman Sachs Growth Equity. Existing investors, such as FirstMark Capital, Volition Capital, and F-Prime Capital, also participated in the round. As part of the deal, Goldman’s Jason Kreuziger is joining TraceLink’s board of… Read More